Prostate cancer: Genomic drivers of resistance to AR therapies

被引：6
|
作者：
Kelsey R.
机构：
来源：
Nature Reviews Urology | 2018年 / 15卷 / 4期
关键词：
D O I：
10.1038/nrurol.2018.18
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：202 / 202
相关论文
共 50 条
  • [1] Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
    Devlies, Wout
    Handle, Florian
    Devos, Gaetan
    Joniau, Steven
    Claessens, Frank
    CANCERS, 2021, 13 (04) : 1 - 17
  • [2] Clinical and genomic resistance to existing and emerging therapies in prostate cancer.
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2018, 78 (16) : 17 - 17
  • [3] Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
    Florian Handle
    Stefan Prekovic
    Christine Helsen
    Thomas Van den Broeck
    Elien Smeets
    Lisa Moris
    Roy Eerlings
    Sarah El Kharraz
    Alfonso Urbanucci
    Ian G. Mills
    Steven Joniau
    Gerhardt Attard
    Frank Claessens
    Scientific Reports, 9
  • [4] Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
    Handle, Florian
    Prekovic, Stefan
    Helsen, Christine
    Van den Broeck, Thomas
    Smeets, Elien
    Moris, Lisa
    Eerlings, Roy
    El Kharraz, Sarah
    Urbanucci, Alfonso
    Mills, Ian G.
    Joniau, Steven
    Attard, Gerhardt
    Claessens, Frank
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] The role of SOX2 in promoting resistance to AR-targeted therapies in prostate cancer
    de Wet, Larischa
    Williams, Anthony
    Gillard, Marc
    Kregel, Steve
    Garcia, Tzintzuni
    McAuley, Erin
    Brown, Ryan
    Vander Griend, Donald
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer
    Chen, William S.
    Aggarwal, Rahul
    Zhang, Li
    Zhao, Shuang G.
    Thomas, George, V
    Beer, Tomasz M.
    Quigley, David A.
    Foye, Adam
    Playdle, Denise
    Huang, Jiaoti
    Lloyd, Paul
    Lu, Eric
    Sun, Duanchen
    Guan, Xiangnan
    Rettig, Matthew
    Gleave, Martin
    Evans, Christopher P.
    Youngren, Jack
    True, Lawrence
    Lara, Primo N.
    Kothari, Vishal
    Xia, Zheng
    Chi, Kim N.
    Reiter, Robert E.
    Maher, Christopher A.
    Feng, Felix Y.
    Small, Eric J.
    Alumkal, Joshi J.
    EUROPEAN UROLOGY, 2019, 76 (05) : 562 - 571
  • [7] Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer.
    Chen, William S.
    Aggarwal, Rahul Raj
    Zhang, Li
    Zhao, Shuang
    Beer, Tomasz M.
    Quigley, David A.
    Foye, Adam
    Playdle, Denise
    Lloyd, Paul
    Rettig, Matthew
    Gleave, Martin
    Evans, Christopher P.
    Lara, Primo
    Kothari, Vishal
    Chi, Kim N.
    Reiter, Robert Evan
    Maher, Christopher
    Feng, Felix Y.
    Small, Eric Jay
    Alumkal, Joshi J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [8] Combination therapies to prevent resistance to androgen deprivation therapies in prostate cancer
    Li, Zhenghong
    Sun, Carrie Qi
    Arnold, Rebecca
    Petros, John A.
    Moreno, Carlos S.
    CANCER RESEARCH, 2019, 79 (13)
  • [9] From Therapy Resistance to Targeted Therapies in Prostate Cancer
    Moreira-Silva, Filipa
    Henrique, Rui
    Jeronimo, Carmen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Mechanisms of Resistance in Antihormone Therapies of Advanced Prostate Cancer
    Thelen, P.
    Gschwend, J.
    Wolff, J-M.
    Miller, K.
    AKTUELLE UROLOGIE, 2016, 47 (01) : 79 - 85
12345